Medtronic’s Paradigm Veo Wireless Insulin Pump Helps Prevent Hypoglycemia

September 2nd, 2009 Editors Medicine, Pediatrics

Medtronic has released a new insulin pump/continuous glucose monitoring system, called Paradigm Veo, that features intelligent protection against episodes of hypoglycemia when the patient is ignoring the dropping sugar levels. After alerting the wearer of an oncoming event, the Paradigm Veo system automatically stops the insulin pump if the patient does not act on the warning. The system is now available for sale to much of the world, but Medtronic is still awaiting FDA clearance to market in the United States.

The Paradigm Veo System includes an insulin pump with a continuous glucose monitoring (CGM) system (provided by means of a separate sensor and transmitter). The patient uses readings from the monitor in conjunction with occasional confirmatory fingerstick blood glucose measurements to understand their current glucose level. Based on these results, the patient then programs the insulin pump to deliver an appropriate amount of insulin. Insulin combats high blood sugar, a key cause of heart disease and other long-term complications in type 1 diabetes.1 However, if data transmitted from the sensor show the patient’s glucose levels have dropped below a defined threshold, the device alarms to alert the patient. If these alarms are ignored, the insulin pump automatically suspends insulin delivery for up to two hours. This helps to protect against potentially dangerous hypoglycemic events.
The Paradigm Veo is equipped with a Low Glucose Suspend18 (LGS) mechanism, which will halt insulin delivery automatically whenever your glucose levels are too low. This can help to reduce the risk of severe hypoglycaemia. And being a CGM-Ready pump, the Paradigm Veo system can offer you the advanced insight of Continuous Glucose Monitoring19 as well. Giving you all the information you need to make the right decisions:

Monitoring and recording your glucose levels 24/7
Allowing you to identify trends and make appropriate adjustments to your lifestyle/treatment
Warning you when your glucose levels stray from your target range

Press release: New Diabetes Device May Be Next Step in Quest for Artificial Pancreas…
Product page: Paradigm Veo…

Upcoming conferences

october

18octallday19alldayWorld Congress on Polycystic Ovarian Syndrome and Fertility, 2018Abu Dhabi, UAE

18octallday19alldayManaging Your Complaints and Obstacles in Post-Market Requirements -- Results from Top Medical Device Observations During an InspectionMinneapolis, MN, USA

Event Details

Post-Market activities, Complaint Handling, MDRs, and Recalls are expensive, time consuming, and often lead to more serious financial consequences. Over 80% of FDA Inspection target observations for lack of compliance in these areas.

By attending this seminar, you will discover:

How to overcome one of the biggest obstacles device manufacturers face
How the FDA expects you to develop and implement proper handling of complaints reportable or non-reportable, product complaint handling and documentation
How and when to file Medical Device Reports (MDR), effective and appropriate communication with the appropriate regulatory agencies in the event of a recall.
How to conduct a correction and removal actions to avoid a recall crisis, including required recordkeeping, expectation from FDA and other regulatory agencies in the event of a recall and key factors in implementing and maintaining compliance with the regulations and real life experiences of FDA.

**New course materials have been added, updated content will include:

Creating Standard Operating Systems (SOPs) for Post-Market Quality Systems and
What to expect from the changes in ORA with Inspection Structure Realignment

This Seminar will have you stop spinning your wheels with nonessential activities, and leave you with a comprehensive learning package that only Rita Hoffman, a former FDA CDRH Recall Branch Chief with experience across the device, drug and veterinary industries can provide.

Spend one and a half days in an interactive course led by Ms. Rita Hoffman, Former FDA CDRH Recall Branch Chief with over 36 years with FDA and leading Industry Expert, who will provide the participants with tools to minimize risk of regulatory enforcement actions.

Time

october 18 (Thursday) - 19 (Friday)

Organizer

Compliance Online 80068SEM

Learn More

Calendar GoogleCal

18octallday19allday18th Global Ophthalmology, Optometry and Glaucoma Conference, 2018Helsinki, Finland

18octallday19alldayBiology and Pathology of Infectious Disease Conference, 2018Helsinki, Finland

18octallday19allday14th Global Biomarkers Summit, 2018Amsterdam, Netherlands

22octallday23alldayInternational Conference on Breast Cancer, 2013Vancouver, British Columbia, Canada